Cargando…
What’s new in neuromuscular pathology 2022: myopathy updates and gene therapies
This compilation of new changes in the diagnosis and treatment of muscle and nerve disease is extracted from the latest publications from the European Neuromuscular Centre International workshops, FDA.gov and clinicaltrials.gov.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Society of Pathologists/The Korean Society for Cytopathology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846006/ https://www.ncbi.nlm.nih.gov/pubmed/36535762 http://dx.doi.org/10.4132/jptm.2022.10.14 |
| _version_ | 1784871052304711680 |
|---|---|
| author | Cai, Chunyu |
| author_facet | Cai, Chunyu |
| author_sort | Cai, Chunyu |
| collection | PubMed |
| description | This compilation of new changes in the diagnosis and treatment of muscle and nerve disease is extracted from the latest publications from the European Neuromuscular Centre International workshops, FDA.gov and clinicaltrials.gov. |
| format | Online Article Text |
| id | pubmed-9846006 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The Korean Society of Pathologists/The Korean Society for Cytopathology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98460062023-01-31 What’s new in neuromuscular pathology 2022: myopathy updates and gene therapies Cai, Chunyu J Pathol Transl Med Newsletter This compilation of new changes in the diagnosis and treatment of muscle and nerve disease is extracted from the latest publications from the European Neuromuscular Centre International workshops, FDA.gov and clinicaltrials.gov. The Korean Society of Pathologists/The Korean Society for Cytopathology 2023-01 2022-12-20 /pmc/articles/PMC9846006/ /pubmed/36535762 http://dx.doi.org/10.4132/jptm.2022.10.14 Text en © 2023 The Korean Society of Pathologists/The Korean Society for Cytopathology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Newsletter Cai, Chunyu What’s new in neuromuscular pathology 2022: myopathy updates and gene therapies |
| title | What’s new in neuromuscular pathology 2022: myopathy updates and gene therapies |
| title_full | What’s new in neuromuscular pathology 2022: myopathy updates and gene therapies |
| title_fullStr | What’s new in neuromuscular pathology 2022: myopathy updates and gene therapies |
| title_full_unstemmed | What’s new in neuromuscular pathology 2022: myopathy updates and gene therapies |
| title_short | What’s new in neuromuscular pathology 2022: myopathy updates and gene therapies |
| title_sort | what’s new in neuromuscular pathology 2022: myopathy updates and gene therapies |
| topic | Newsletter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846006/ https://www.ncbi.nlm.nih.gov/pubmed/36535762 http://dx.doi.org/10.4132/jptm.2022.10.14 |
| work_keys_str_mv | AT caichunyu whatsnewinneuromuscularpathology2022myopathyupdatesandgenetherapies |